Tag: Pfizer

Lupus and IBD Research Partnerships

Over the last year 23andMe has launched two research initiatives with Pfizer, one to study inflammatory bowel disease and the other to study lupus. We’re pretty optimistic about the work done so far as we continue to recruit patients to participate in these two important research projects, so it’s nice to ...

Read more

23andMe Hangs out with the Lupus Research Institute

Researchers know that genetics, as well as environmental and hormonal influences, play a role in the development of lupus, but we still have a lot to learn about this as-yet incurable autoimmune disease. This spring, 23andMe and Pfizer launched a study into the genetics of lupus. Working in collaboration ...

Read more

Living With Lupus

You want to know a little about what it’s like living with lupus, ask a first-time author, a “fiery Latina,” or Mrs. New York USA Universal. Those are just a few of the bloggers we’ve been following lately who each offer different insight on the day-in and day-out challenges of living with this chronic and ...

Read more

World IBD Day And Research

In less than a year’s time, 23andMe is more than halfway to its goal of enrolling 10,000 patients in its study of Inflammatory Bowel Disease (IBD), which will look more deeply at how genetics and environment affect the condition. As we recognize World IBD Day May 19th, we wanted to update you on our ...

Read more

Learn More About 23andMe’s Lupus Study

Download Lupus Community Research Badge Image ...

Read more

Learn More About 23andMe’s IBD Study

Download the IBD Research Community Badge Image ...

Read more

23andMe Launches Lupus Research Community

23andMe, Pfizer, Inc. and the Lupus Research Institute are launching a collaborative study focused on the genetics of the autoimmune disease known as lupus. The aim is to quickly enroll 5,000 people with the disease, which affects about 1.5 million people in the United States alone. “The ability to ...

Read more

Drug Development’s Long And Winding Road

Before a medicine reaches pharmacy shelves, it goes through extensive and rigorous evaluation to prove it is safe and effective. We want to shed some light on a few of the steps involved in drug development and highlight how the work being done by 23andMe with the Inflammatory Bowel Disease Study can help ...

Read more

23andMe’s Recent Research Collaborations

This week 23andMe announced a collaboration with Pfizer Inc, allowing researchers with the drug maker to leverage 23andMe’s unique platform to conduct genome-wide associations studies, surveys and clinical trial recruitment. The news follows a collaboration begun over the summer between 23andMe and Pfizer ...

Read more

Raising Awareness About IBD

Over the summer 23andMe launched a collaborative study with Pfizer to study the research inflammatory bowel disease (IBD). We've been encouraged by the number of people diagnosed with either Crohn's disease and ulcerative colitis who have joined the study. On top of the research we're doing, we also ...

Read more

Return to top